Valneva SE (EPA:VLA)

France · Delayed Price · Currency is EUR

2.363

-0.036 (-1.50%)

Oct 23, 2026, 9:25 AM CEST

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Development and Commercialization of Prophylactic Vaccines	174.66M	169.58M	153.71M	361.30M	348.09M
Total	174.66M	169.58M	153.71M	361.30M	348.09M

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	53.61M	48.59M	32.96M	-23.80M	40.34M
Canada	30.13M	32.32M	28.19M	18.90M	4.23M
Germany	17.47M	18.37M	13.50M	68.53M	726.00K
Rest Of World	8.90M	4.69M	16.31M	17.36M	134.00K
Nordics	13.90M	13.94M	12.70M	12.04M	2.44M
United Kingdom	12.64M	19.49M	20.27M	181.13M	2.71M
Other Europe	13.88M	9.06M	9.34M	18.74M	2.08M
France	14.67M	7.22M	5.87M	46.61M	1.00M
Austria	9.47M	15.90M	14.58M	21.79M	9.34M
Total	174.66M	169.58M	153.71M	361.30M	62.98M